Jose Luis C. P.
- Country
- Spain
- Department
- Hepatology
Research Overview
- A Registry Study of Treatment With Bulevirtide in Participants With Chronic Hepatitis D Infection
- Phase 2 Randomized, Placebo-Controlled Study of the Efficacy and Safety of Vamifeport in Adults with HFE-Related Hereditary Hemochromatosis
- Randomized, double-blind and multicentric study to assess the efficiency, security and tolerability of the faecal microbiota transfer in capsule form vs. placebo for the treatment of patients with non-alcoholic steatohepatitis (EMOTION)
Data & Insights
Has run more than one trial at 219 of 426 partner sites.
Specializations
Liver Cancer Research
This investigator specializes in the treatment of advanced hepatocellular carcinoma, focusing on innovative therapeutic approaches for patients who have not received prior systemic treatment. Their work encompasses evaluation of various combination therapies including immunotherapy combinations and targeted treatments.
- Advanced HCC Management
- Intermediate-stage HCC Treatment
- First-line Therapy Development
Chronic Liver Conditions
The investigator conducts research in various chronic liver conditions, including Primary Sclerosing Cholangitis and Primary Biliary Cholangitis. Their work extends to the study of advanced chronic liver disease and its complications.
- Cholestatic Liver Diseases
- Chronic Liver Disease Management
- Liver Failure Complications
Metabolic Liver Disease
Research focuses on non-alcoholic steatohepatitis and metabolic dysfunction-associated steatohepatitis. The investigator explores innovative therapeutic approaches including faecal microbiota transfer and novel pharmaceutical interventions.
- NASH/MASH Treatment
- Liver Fibrosis Management
- Metabolic Liver Disease Therapy
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.